Schizophrenia Study In Adults
Schizophrenia
About this trial
This is an interventional treatment trial for Schizophrenia focused on measuring Talnetant, schizophrenia, NK3 receptor antagonist, psychosis
Eligibility Criteria
Inclusion Criteria: Patient must meet diagnostic criteria for schizophrenia. Exclusion Criteria: Patients with other psychotic disorders. Patients whose condition is due to the direct physiological effects of a substances (e.g., drug abuse) or a general medical condition. Patients with a history of autistic disorder or another pervasive developmental disorder. Patients with epilepsy or a history of seizures requiring treatment. Patients who are excluded from taking the drug risperidone. Patients who pose a current serious suicidal or homicidal risk. Patients who are adequately stabilized on their treatment.
Sites / Locations
- GSK Clinical Trial Call Center
- GSK Clinical Trial Call Center
- GSK Clinical Trial Call Center
- GSK Clinical Trial Call Center
- GSK Clinical Trial Call Center
- GSK Clinical Trial Call Center
- GSK Clinical Trial Call Center
- GSK Clinical Trial Call Center
- GSK Clinical Trial Call Center
- GSK Clinical Trial Call Center
- GSK Clinical Trial Call Center
- GSK Clinical Trial Call Center
- GSK Clinical Trial Call Center
- GSK Clinical Trial Call Center
- GSK Clinical Trial Call Center
- GSK Clinical Trial Call Center
- GSK Clinical Trial Call Center
- GSK Clinical Trial Call Center
- GSK Clinical Trial Call Center
- GSK Clinical Trial Call Center
- GSK Clinical Trial Call Center
- GSK Clinical Trial Call Center
- GSK Clinical Trial Call Center
- GSK Clinical Trial Call Center
- GSK Clinical Trial Call Center
- GSK Clinical Trial Call Center
- GSK Clinical Trial Call Center
- GSK Clinical Trial Call Center
- GSK Clinical Trial Call Center
- GSK Clinical Trial Call Center
- GSK Clinical Trial Call Center